Hinderliter Alan L, Sherwood Andrew, Craighead Linda W, Lin Pwa-Hwa, Watkins Lana, Babyak Michael A, Blumenthal James A
Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Am J Hypertens. 2014 May;27(5):734-41. doi: 10.1093/ajh/hpt183. Epub 2013 Oct 1.
There is a paucity of data describing the sustained benefits of lifestyle interventions on health behaviors and blood pressure (BP).
We examined the persistence of changes in health habits and BP in the ENCORE study, a trial in which 144 overweight individuals with above-normal BP were randomized to one of the following 16-week interventions: Dietary Approaches to Stop Hypertension (DASH) diet alone (DASH-A), DASH diet plus a behavioral weight management intervention (DASH-WM), or Usual Care. Follow-up assessments were conducted 8 months after the end of treatment.
At 16 weeks, systolic BP was reduced by 16.1 (95% confidence interval (CI) = 13.0-19.2) mm Hg in the DASH-WM group, 11.2 (95% CI = 8.1-14.3) mm Hg in the DASH-A group, and 3.4 (95% CI = 0.4-6.4) mm Hg in the Usual Care group. A decrease in BP persisted for 8 months, with systolic BP lower than baseline by 11.7 (95% CI = 8.1-15.3) mm Hg in the DASH-WM group, 9.5 (95% CI = 6.7-12.1) mm Hg in the DASH-A group, and 3.9 (95% CI = 0.5-7.3) mm Hg in the Usual Care group (P < 0.001 for active treatments vs. Usual Care). DASH-WM subjects lost 8.7 kg during the intervention and remained 6.3 kg lighter on follow-up examination. Changes in diet content were sustained in both DASH intervention groups. Among those who participated in DASH-WM, however, caloric intake was no longer lower, and only 21% reported still exercising regularly 8 months after completing the intervention.
Changes in dietary habits, weight, and BP persisted for 8 months after completion of the 16-week ENCORE program, with some attenuation of the benefits. Additional research is needed to identify effective methods to promote long-term maintenance of the benefits of lifestyle modification programs.
Clinicaltrials.gov identifier: NCT00571844.
关于生活方式干预对健康行为和血压(BP)的持续益处的数据匮乏。
我们在ENCORE研究中考察了健康习惯和血压变化的持续性,该试验将144名血压高于正常水平的超重个体随机分为以下16周干预措施之一:单纯的饮食预防高血压(DASH)饮食(DASH-A)、DASH饮食加行为体重管理干预(DASH-WM)或常规护理。在治疗结束8个月后进行随访评估。
在16周时,DASH-WM组收缩压降低了16.1(95%置信区间(CI)=13.0-19.2)mmHg,DASH-A组降低了11.2(95%CI=8.1-14.3)mmHg,常规护理组降低了3.4(95%CI=0.4-6.4)mmHg。血压降低持续了8个月,DASH-WM组收缩压比基线低11.7(95%CI=8.1-15.3)mmHg,DASH-A组低9.5(95%CI=6.7-12.1)mmHg,常规护理组低3.9(95%CI=0.5-7.3)mmHg(积极治疗组与常规护理组相比,P<0.001)。DASH-WM组受试者在干预期间体重减轻了8.7kg,随访检查时仍轻6.3kg。两个DASH干预组的饮食内容变化均持续存在。然而,在参与DASH-WM的人群中,热量摄入不再较低,并且在完成干预8个月后只有21%的人报告仍在定期锻炼。
在为期16周的ENCORE项目完成后,饮食习惯、体重和血压的变化持续了8个月,但益处有所减弱。需要进一步研究以确定促进生活方式改变项目益处长期维持 的有效方法。
Clinicaltrials.gov标识符:NCT00571844。